Clinical Trials · NCT07030621
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- RenJi Hospital
- Enrollment
- 436
- Start date
- Jul 2025
- Locations
- 1 site, China
- Primary endpoint
- mRS at 90-days